Deficiency of Adenomatous Polyposis Coli protein in sporadic colorectal adenomas and its associations with clinical phenotype and histology

被引:2
|
作者
Bortlik, Martin
Vitkova, Ivana
Papezova, Martina
Kohoutova, Milada
Novotny, Ales
Adamec, Stanislav
Chalupna, Petra
Lukas, Milan
机构
[1] Charles Univ, Sch Med 1, Gen Fac Hosp, Internal Dept 4,Gastroenterol Ctr, Prague 12808 2, Czech Republic
[2] Charles Univ, Sch Med 1, Gen Fac Hosp, Dept Pathol, Prague, Czech Republic
[3] Charles Univ, Sch Med 1, Gen Fac Hosp, Inst Biol & Med Genet, Prague, Czech Republic
关键词
Adenomatous Polyposis Coli protein; adenoma; immunohistochemistry; histology;
D O I
10.3748/wjg.v12.i24.3901
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To evaluate the frequency of the loss of the Adenomatous Polyposis Coli (APC) protein and to compare the APC status with the characteristics of colorectal adenomas. Methods: Immunohistochemical analysis of the APC protein was performed on 118 adenomas and the results were compared with parameters of malignant potential, location of adenomas, macroscopic appearance and age of the patients. Results: A complete loss of the APC protein was found in 28 (24%) adenomas, while 90 (76%) were APC positive. The mean size of adenomas was 13.5 +/- 14.2 mm (95% CI 10.5-16.5) in APC-positive, and 13.8 +/- 15.5 mm (95% CI 7.8-19.8) in APC-negative adenomas (P=0.364). Statistical analysis revealed no difference between APC-positive and negative adenomas as to the histological type (P=0.327) and grade of dysplasia (P=0.494). We found that even advanced adenomas did not differ in their APC status from the non-advanced tumors (P=0.414). Finally, no difference was found when the location (P=0.157), macroscopic appearance (P=0.571) and age of patients (P=0.438) were analysed and compared between both APC positive and negative adenomas. Conclusion: Most adenomas expressed full-length APC protein, suggesting that protein expression is not a reliable marker for assessment of APC gene mutation. Complete loss of APC protein did not influence morphology, location, or appearance of adenomas, nor was it affected by the patient's age. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:3901 / 3905
页数:5
相关论文
共 34 条
  • [21] The role of adenomatous polyposis coli protein in prevention of colorectal carcinoma in the APC+/APC1638N mouse model
    Cierna, Z.
    Adamcikova, Z.
    Zajac, V.
    Wachsmannova, L.
    Stevurkova, V.
    Hainova, K.
    Holec, V.
    Janega, P.
    Janegova, A.
    Klincova, E.
    Babal, P.
    VIRCHOWS ARCHIV, 2011, 459 : S162 - S162
  • [22] MICROSATELLITE INSTABILITY IN COLORECTAL ADENOCARCINOMA CELL-LINES THAT HAVE FULL-LENGTH ADENOMATOUS POLYPOSIS-COLI PROTEIN
    HEINEN, CD
    RICHARDSON, D
    WHITE, R
    GRODEN, J
    CANCER RESEARCH, 1995, 55 (21) : 4797 - 4799
  • [23] Crypt cell proliferation state in the human colon. Validation of results obtained by whole crypt microdissection and the findings in patients with familial adenomatous polyposis, sporadic adenomas and colorectal cancer
    Mills, SJ
    Mathers, JC
    Chapman, PD
    Burn, J
    Gunn, A
    BRITISH JOURNAL OF SURGERY, 1998, 85 : 84 - 84
  • [24] Rho GTPase Cdc42 Is a Direct Interacting Partner of Adenomatous Polyposis Coli Protein and Can Alter Its Cellular Localization
    Sudhaharan, Thankiah
    Goh, Wah Ing
    Sem, Kai Ping
    Lim, Kim Buay
    Bu, Wenyu
    Ahmed, Sohail
    PLOS ONE, 2011, 6 (02):
  • [25] APC (adenomatous polyposis coli) protein is recruited to the cell cortex through its COOH-terminal PDZ-binding domain
    Mimori-Kiyosue, Y
    Tsukita, S
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 308A - 309A
  • [26] Activator protein 2α associates with adenomatous polyposis coli/β-catenin and inhibits β-catenin/T-cell factor transcriptional activity in colorectal cancer cells
    Li, QJ
    Dashwood, RH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) : 45669 - 45675
  • [27] Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas
    Gismondi, V
    Meta, M
    Bonelli, L
    Radice, P
    Sala, P
    Bertario, L
    Viel, A
    Fornasarig, M
    Arrigoni, A
    Gentile, M
    De Leon, MP
    Anselmi, L
    Mareni, C
    Bruzzi, P
    Varesco, L
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (05) : 680 - 684
  • [28] Chemoprevention of colorectal adenomas in familial adenomatous polyposis with low-dose sulindac:: Clinical outcome, influence on oncogenes, and growth factors:: Interim results of a five-year study course
    Winde, G
    Schmid, KW
    Müller, O
    Bartsch, H
    Osswald, H
    FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 177 - 189
  • [29] Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia evidence for a founder effect
    Rozen, P
    Naiman, T
    Strul, H
    Taussky, P
    Karminsky, N
    Shomrat, R
    Samuel, Z
    Yaron, Y
    Orr-Urtreger, A
    CANCER, 2002, 94 (10) : 2561 - 2568
  • [30] Immunohistochemical evaluation of adenomatous polyposis coli, β-catenin, c-Myc, cyclin D1, p53, and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps
    Hassan, A
    Yerian, LM
    Kuan, SF
    Xiao, SY
    Hart, J
    Wang, HLL
    HUMAN PATHOLOGY, 2004, 35 (03) : 328 - 334